Patent 9636301 was granted and assigned to Arbutus Biopharma Corporation on May, 2017 by the United States Patent and Trademark Office.
The present invention provides a novel in vitro release assay for the accurate, reproducible quantitation of vincristine sulfate release from liposomes.